253 related articles for article (PubMed ID: 22618571)
1. A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Meiri E; Mueller WC; Rosenwald S; Zepeniuk M; Klinke E; Edmonston TB; Werner M; Lass U; Barshack I; Feinmesser M; Huszar M; Fogt F; Ashkenazi K; Sanden M; Goren E; Dromi N; Zion O; Burnstein I; Chajut A; Spector Y; Aharonov R
Oncologist; 2012; 17(6):801-12. PubMed ID: 22618571
[TBL] [Abstract][Full Text] [Related]
2. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
Rosenwald S; Gilad S; Benjamin S; Lebanony D; Dromi N; Faerman A; Benjamin H; Tamir R; Ezagouri M; Goren E; Barshack I; Nass D; Tobar A; Feinmesser M; Rosenfeld N; Leizerman I; Ashkenazi K; Spector Y; Chajut A; Aharonov R
Mod Pathol; 2010 Jun; 23(6):814-23. PubMed ID: 20348879
[TBL] [Abstract][Full Text] [Related]
3. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
[TBL] [Abstract][Full Text] [Related]
4. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
[TBL] [Abstract][Full Text] [Related]
6. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
7. Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.
Pentheroudakis G; Pavlidis N; Fountzilas G; Krikelis D; Goussia A; Stoyianni A; Sanden M; St Cyr B; Yerushalmi N; Benjamin H; Meiri E; Chajut A; Rosenwald S; Aharonov R; Spector Y
Mol Cancer; 2013 Jun; 12():57. PubMed ID: 23758919
[TBL] [Abstract][Full Text] [Related]
8. Efficient identification of miRNAs for classification of tumor origin.
Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
[TBL] [Abstract][Full Text] [Related]
9. Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin.
Ye Q; Wang Q; Qi P; Chen J; Sun Y; Jin S; Ren W; Chen C; Liu M; Xu M; Ji G; Yang J; Nie L; Xu Q; Huang D; Du X; Zhou X
J Mol Diagn; 2020 Sep; 22(9):1139-1150. PubMed ID: 32610162
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
Ferracin M; Pedriali M; Veronese A; Zagatti B; Gafà R; Magri E; Lunardi M; Munerato G; Querzoli G; Maestri I; Ulazzi L; Nenci I; Croce CM; Lanza G; Querzoli P; Negrini M
J Pathol; 2011 Sep; 225(1):43-53. PubMed ID: 21630269
[TBL] [Abstract][Full Text] [Related]
11. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
van Laar RK; Ma XJ; de Jong D; Wehkamp D; Floore AN; Warmoes MO; Simon I; Wang W; Erlander M; van't Veer LJ; Glas AM
Int J Cancer; 2009 Sep; 125(6):1390-7. PubMed ID: 19536816
[TBL] [Abstract][Full Text] [Related]
14. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
[TBL] [Abstract][Full Text] [Related]
15. An integrated tool for determining the primary origin site of metastatic tumours.
Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
[TBL] [Abstract][Full Text] [Related]
17. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
18. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
Pentheroudakis G; Spector Y; Krikelis D; Kotoula V; Meiri E; Malamou-Mitsi V; Fountzilas G; Sanden M; Pavlidis N; Benjamin H; Aharonov R
Clin Exp Metastasis; 2013 Apr; 30(4):431-9. PubMed ID: 23124598
[TBL] [Abstract][Full Text] [Related]
19. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
[TBL] [Abstract][Full Text] [Related]
20. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Huang VJ; Erlander MG; Brachtel EF; Dry SM
Mod Pathol; 2014 Jan; 27(1):44-54. PubMed ID: 23846576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
